Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Whitehawk Therapeutics, Inc. (WHWK) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-17.75M |
|
-- |
|
-- |
|
$19.55M |
|
$-19.55M |
|
$1.80M |
|
$-17.75M |
|
$-17.57M |
|
$-17.75M |
|
$-17.75M |
|
$-17.75M |
|
$-17.57M |
|
$-19.55M |
|
$-20.26M |
|
69.20M |
|
69.20M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$165.04M |
|
$0.00M |
|
$1.98M |
|
$167.02M |
|
$9.85M |
|
-- |
|
-- |
|
$9.85M |
|
$157.17M |
|
$157.17M |
|
$157.17M |
|
47.13M |
|
| Cash Flow Statement Financials | |
$-80.20M |
|
$-4.96M |
|
$94.35M |
|
$28.73M |
|
$37.93M |
|
$9.20M |
|
$7.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.76 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-80.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.29% |
|
-11.29% |
|
-10.63% |
|
-11.29% |
|
$3.33 |
|
$-1.17 |
|
$-1.16 |
|